Companies similar to Alnylam Pharmaceuticals (ALNY)

Health Care

Alnylam Pharmaceuticals (ALNY)'s closest peers include Ionis Pharmaceuticals (IONS), Moderna (MRNA) and Regeneron Pharmaceuticals (REGN). This peer set is drawn from ALNY's enriched company profile and is informational only — not financial advice.

Similar companies

• Ionis PharmaceuticalsIONSHealth Care

  Pioneer in RNA-targeted antisense medicines with seven commercialized products and expanding late-stage pipeline across rare neurological and cardiometabolic…

  $54.65 (as of 2026-07-16) · market cap $9.0B

• ModernaMRNAHealth Care

  Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and…

  $63.15 (as of 2026-07-16) · market cap $25.1B

• Regeneron PharmaceuticalsREGNHealth Care

  Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…

  $678.94 (as of 2026-07-16) · market cap $70.5B

Not quite? Describe exactly what you want →

Peers are drawn from ALNY's enriched profile (the same similarity signal the chat uses for "companies like ALNY"). See the full profile: Alnylam Pharmaceuticals (ALNY).

Last updated 2026-07-16.

Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.